Conquering Hypertension in Vietnam: Solutions at Grassroots Level
HY-TREC
2 other identifiers
interventional
671
1 country
1
Brief Summary
The objectives of the proposed project are to evaluate the implementation and effectiveness of two multi-faceted community and clinic-based strategies on the control of elevated blood pressure (BP) among adults in Vietnam via a cluster-randomized trial design. Sixteen communities will be randomized to either an intervention (8 communities) or comparison group (8 communities). Eligible and consenting adult study participants with HTN (n = 680) will be assigned to intervention/comparison status based on the community in which they reside.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Nov 2019
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2018
CompletedFirst Posted
Study publicly available on registry
July 18, 2018
CompletedStudy Start
First participant enrolled
November 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedMay 11, 2023
May 1, 2023
3.2 years
May 31, 2018
May 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in systolic blood pressure at 12 months
Changes in systolic blood pressure will be assessed in both study groups at several follow-up time points.
At baseline and at 3, 6, and 12 months after trial enrollment
Secondary Outcomes (3)
Change from baseline in diastolic blood pressure at 12 months
At baseline and at 3, 6, and 12 months after trial enrollment
Change from baseline in medication adherence self-efficacy score at 12 months
At baseline and 12 months after trial enrollment
Changes from the baseline in proportions of patients with risk factors for CVD at 12 months
At baseline and 12 months after trial enrollment
Study Arms (2)
Comparison group
ACTIVE COMPARATORVietnam National Hypertension Program: a training program for health care workers and a health educational program for general public.
Intervention group
EXPERIMENTALVietnam National Hypertension Program including training program for health care workers and an health educational program for general public. PLUS Three selected enhancements integrated into routine clinical care: 1. expanded community health worker services; 2. home blood pressure self-monitoring; and 3. a "storytelling intervention".
Interventions
A training program for health care workers including physicians and nurses and a health educational program for general public regarding hypertension management at community level will be implemented
A training program will be implemented for community health workers regarding hypertension management at community level so that they can assist patients better manage their blood pressure at home.
The storytelling intervention consists of interactive, literacy-appropriate, and culturally sensitive multimedia storytelling modules for motivating behavior change through the power of patients speaking in their own voice. Based on preferences that emerged during the researchers' formative work with the partnering rural communities, the storytelling intervention will be delivered by DVD, with serial installments at baseline and at 3, 6, and 12 months after trial enrollment.
Patients with hypertension will be provided blood pressure monitors and guided to self-measure their blood pressure and to record their blood pressure daily at home.
Eligibility Criteria
You may qualify if:
- residence in a study commune;
- at least 25 years old;
- presence of uncontrolled HTN based on the screening process described previously and
- willingness to provide informed consent.
You may not qualify if:
- participation in another hypertension research study;
- pregnant;
- advanced cognitive impairment; or
- previous participation in developing or having exposure to the hypertension storytelling modules.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ministry of Health, Vietnamlead
- University of Massachusetts, Worcestercollaborator
- Baylor Research Institutecollaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
Health Strategy and Policy Institute
Hanoi, 10000, Vietnam
Related Publications (3)
Nguyen HL, Ha DA, Tran OT, Phan VH, Nguyen CT, Nguyen GH, Nguyen TT, Le TT, Goldberg RJ, Wang B, Tang ET, Chiriboga G, Budhwani H, Allison JJ. Conquering hypertension in Vietnam: 12- month follow up results from a cluster-randomised controlled trial. Lancet Reg Health West Pac. 2024 Jul 1;48:101123. doi: 10.1016/j.lanwpc.2024.101123. eCollection 2024 Jul.
PMID: 39045484DERIVEDNguyen HL, Tran OT, Ha DA, Phan VH, Nguyen CT, Nguyen GH, Nguyen TT, Chiriboga G, Goldberg RJ, Allison JJ. Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam. PLoS One. 2021 Jul 15;16(7):e0253664. doi: 10.1371/journal.pone.0253664. eCollection 2021.
PMID: 34264973DERIVEDHa DA, Tran OT, Nguyen HL, Chiriboga G, Goldberg RJ, Phan VH, Nguyen CT, Nguyen GH, Pham HV, Nguyen TT, Le TT, Allison JJ. Conquering hypertension in Vietnam-solutions at grassroots level: study protocol of a cluster randomized controlled trial. Trials. 2020 Nov 27;21(1):985. doi: 10.1186/s13063-020-04917-8.
PMID: 33246495DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tran Thi Mai Oanh, PhD
Health Strategy and Policy Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Director of Health Strategy and Policy Institute
Study Record Dates
First Submitted
May 31, 2018
First Posted
July 18, 2018
Study Start
November 7, 2019
Primary Completion
January 31, 2023
Study Completion
April 30, 2023
Last Updated
May 11, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share